220 related articles for article (PubMed ID: 36764357)
1. The Role of LRRK2 in Intracellular Organelle Dynamics.
Boecker CA
J Mol Biol; 2023 Jun; 435(12):167998. PubMed ID: 36764357
[TBL] [Abstract][Full Text] [Related]
2. LRRK2 and Rab GTPases.
Pfeffer SR
Biochem Soc Trans; 2018 Dec; 46(6):1707-1712. PubMed ID: 30467121
[TBL] [Abstract][Full Text] [Related]
3. Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease.
Cookson MR
Biochem Soc Trans; 2016 Dec; 44(6):1603-1610. PubMed ID: 27913668
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
[TBL] [Abstract][Full Text] [Related]
5. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
[TBL] [Abstract][Full Text] [Related]
6. Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes.
Wang X; Bondar VV; Davis OB; Maloney MT; Agam M; Chin MY; Cheuk-Nga Ho A; Ghosh R; Leto DE; Joy D; Calvert MEK; Lewcock JW; Di Paolo G; Thorne RG; Sweeney ZK; Henry AG
Elife; 2023 Oct; 12():. PubMed ID: 37874617
[TBL] [Abstract][Full Text] [Related]
7. The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A.
Rivero-Ríos P; Romo-Lozano M; Madero-Pérez J; Thomas AP; Biosa A; Greggio E; Hilfiker S
J Biol Chem; 2019 Mar; 294(13):4738-4758. PubMed ID: 30709905
[TBL] [Abstract][Full Text] [Related]
8. An Update on the Interplay between LRRK2, Rab GTPases and Parkinson's Disease.
Komori T; Kuwahara T
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002327
[TBL] [Abstract][Full Text] [Related]
9. Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes.
Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Romo Lozano M; Rivero-Ríos P; Hilfiker S
Biochem Soc Trans; 2017 Feb; 45(1):147-154. PubMed ID: 28202668
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of Rab29 at Ser185 regulates its localization and role in the lysosomal stress response in concert with LRRK2.
Komori T; Kuwahara T; Fujimoto T; Sakurai M; Koyama-Honda I; Fukuda M; Iwatsubo T
J Cell Sci; 2023 Jul; 136(14):. PubMed ID: 37365944
[TBL] [Abstract][Full Text] [Related]
11. LRRK2 phosphorylation of Rab GTPases in Parkinson's disease.
Pfeffer SR
FEBS Lett; 2023 Mar; 597(6):811-818. PubMed ID: 36114007
[TBL] [Abstract][Full Text] [Related]
12. Insights into the cellular consequences of LRRK2-mediated Rab protein phosphorylation.
Fasiczka R; Naaldijk Y; Brahmia B; Hilfiker S
Biochem Soc Trans; 2023 Apr; 51(2):587-595. PubMed ID: 36929701
[TBL] [Abstract][Full Text] [Related]
13. Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease.
Taylor M; Alessi DR
Curr Opin Cell Biol; 2020 Apr; 63():102-113. PubMed ID: 32036294
[TBL] [Abstract][Full Text] [Related]
14. Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
Mamais A; Kluss JH; Bonet-Ponce L; Landeck N; Langston RG; Smith N; Beilina A; Kaganovich A; Ghosh MC; Pellegrini L; Kumaran R; Papazoglou I; Heaton GR; Bandopadhyay R; Maio N; Kim C; LaVoie MJ; Gershlick DC; Cookson MR
PLoS Biol; 2021 Dec; 19(12):e3001480. PubMed ID: 34914695
[TBL] [Abstract][Full Text] [Related]
15. Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases.
Steger M; Tonelli F; Ito G; Davies P; Trost M; Vetter M; Wachter S; Lorentzen E; Duddy G; Wilson S; Baptista MA; Fiske BK; Fell MJ; Morrow JA; Reith AD; Alessi DR; Mann M
Elife; 2016 Jan; 5():. PubMed ID: 26824392
[TBL] [Abstract][Full Text] [Related]
16. Development of phospho-specific Rab protein antibodies to monitor
Lis P; Burel S; Steger M; Mann M; Brown F; Diez F; Tonelli F; Holton JL; Ho PW; Ho SL; Chou MY; Polinski NK; Martinez TN; Davies P; Alessi DR
Biochem J; 2018 Jan; 475(1):1-22. PubMed ID: 29127256
[TBL] [Abstract][Full Text] [Related]
17. LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis.
Eguchi T; Kuwahara T; Sakurai M; Komori T; Fujimoto T; Ito G; Yoshimura SI; Harada A; Fukuda M; Koike M; Iwatsubo T
Proc Natl Acad Sci U S A; 2018 Sep; 115(39):E9115-E9124. PubMed ID: 30209220
[TBL] [Abstract][Full Text] [Related]
18. LRRK2 activation controls the repair of damaged endomembranes in macrophages.
Herbst S; Campbell P; Harvey J; Bernard EM; Papayannopoulos V; Wood NW; Morris HR; Gutierrez MG
EMBO J; 2020 Sep; 39(18):e104494. PubMed ID: 32643832
[TBL] [Abstract][Full Text] [Related]
19. Preclinical modeling of chronic inhibition of the Parkinson's disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo.
Kluss JH; Mazza MC; Li Y; Manzoni C; Lewis PA; Cookson MR; Mamais A
Mol Neurodegener; 2021 Mar; 16(1):17. PubMed ID: 33741046
[TBL] [Abstract][Full Text] [Related]
20.
Wauters F; Cornelissen T; Imberechts D; Martin S; Koentjoro B; Sue C; Vangheluwe P; Vandenberghe W
Autophagy; 2020 Feb; 16(2):203-222. PubMed ID: 30945962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
